Results 201 to 210 of about 42,337 (292)

Advances in the role of the IGF signaling system in myelodysplastic syndromes and acute myeloid leukemia. [PDF]

Front Oncol
Wang Y, Dong X, Tao S, Chen Q, Chen Y, Zhang L, Shi Y, He Z, Yu L, Wang C.   +9 more
europepmc   +1 more source

Myelodysplastic Syndrome in a Patient With Cronkhite‐Canada Syndrome

Clinical Case Reports, Volume 13, Issue 8, August 2025.
ABSTRACT Cronkhite‐Canada Syndrome (CCS) is a rare non‐hereditary gastroenterological polyposis syndrome without a clear etiology. Myelodysplastic syndromes (MDS) are clonal hematological disorders. Immune dysregulation has been posited as a contributor to the development of both. A 70‐year‐old man developed chronic diarrhea, dysgeusia, and onycholysis.
Kevin G. Shim, Kevork Khadarian, Jewel Samadder, Jiehao Zhou, Cecilia Arana Yi   +4 more
wiley   +1 more source

Pathogenesis and inflammaging in myelodysplastic syndrome. [PDF]

Haematologica
Villaume MT, Savona MR.
europepmc   +1 more source

A Genetic Twist: Cytologic Evaluation of Pancreatic Adenocarcinoma and Steatohepatitic Hepatocellular Carcinoma in a Patient With a Rare POLE Mutation

Diagnostic Cytopathology, Volume 53, Issue 8, Page E160-E164, August 2025.
ABSTRACT Mutations in the DNA polymerase epsilon (POLE) gene are associated with an increased risk of various malignancies, including colorectal and other gastrointestinal, endometrial, ovarian, breast, and brain cancers. In extremely rare cases, POLE mutations have also been associated with pancreatic and hepatobiliary carcinomas.
Lynn Messersmith, Areeba H. Rizvi, Dina El‐Rayes, Jimmie Stewart III   +3 more
wiley   +1 more source

Loss of FTH1 Induces Ferritinophagy-Mediated Ferroptosis in Anaemia of Myelodysplastic Syndromes. [PDF]

J Cell Mol Med
Yang L, Zhang M, Liu M, Yu Y, Zhang Y, Yang J, Xing L, Shao Z, Wang H.   +8 more
europepmc   +1 more source

The molecular prognostic scoring system for normal karyotype myelodysplastic syndromes. [PDF]

J Transl Med
Wang W, Zhang Y, Yang W, Liu X, Jiang L, Lang W, Luo Y, Zhou X, Wang L, Ye L, Xu Y, Ma L, Tong H.   +12 more
europepmc   +1 more source

Concurrent diagnosis of chronic lymphocytic leukemia and myelodysplastic syndrome

, 1997
L. Sylvester, P C Nowell, Hugh Bonner, Lisa A. Moreau, Jonni S. Moore   +4 more
openalex   +1 more source

Intersecting Anemias: PARP Inhibitor‐Induced Toxicity and Autoimmune Hemolysis—A Case Report

eJHaem, Volume 6, Issue 4, August 2025.
ABSTRACT We present a case of a 71‐year‐old woman with a history of high‐grade serous ovarian adenocarcinoma, treated with neoadjuvant chemotherapy, surgery, and adjuvant chemotherapy. A maintenance treatment combining bevacizumab and olaparib was introduced consecutively. Bevacizumab was stopped 7 months later due to neurological complications.
Julien Dereme, Konstantinos Asonitis, Francesco Grandoni, Aikaterini Liapi, Apostolos Sarivalasis, Gerasimos Tsilimidos   +5 more
wiley   +1 more source

Neurophysiological markers in myelodysplastic syndromes: Insights into peripheral neuropathy. [PDF]

Br J Haematol
Möhn N.
europepmc   +1 more source

Prognostic Value of Geriatric Characteristics in Allogeneic Haematopoietic Stem Cell Transplant Recipients Aged Over 60 Years

eJHaem, Volume 6, Issue 4, August 2025.
ABSTRACT Introduction Allogeneic haematopoietic stem cell transplant (alloHSCT) offers a curative option for older adults with haematological malignancies. The use of geriatric assessments has transformed the landscape of haemato‐oncology care by improving risk stratification.
Xiu Hue Lee, Chieh Hwee Ang, Tertius Tansloan Tuy, Jeffrey Kim Siang Quek, Hein Than, Francesca Lorraine Wei Inng Lim, Yeow Tee Goh, Yeh Ching Linn, William Ying Khee Hwang, Aloysius Yew Leng Ho, Lawrence Cheng Kiat Ng   +10 more
wiley   +1 more source